Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective
(Q74450936)
scientific article published on 01 November 1998
scientific article published on 01 November 1998
Language:
Current Data About
Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective
other details
| description | scientific article published on 01 November 1998 |
External Links
| (P356) |
10.1016/S0959-8049(98)00260-3
|
| (P698) |
10023312
|